153 The new drug was well tolerated and showed a trend towards improved gas transfer. 154 Mesenchymal autologous stem‐cell therapy has had promising results in ischaemic cardiomyopathy and HF. 155 , 156 The Phase II CONCERT‐HF trial demonstrated that the combination of mesenchymal stem cells and c‐kit‐positive cardiac cells was associated w
← all excerpts
Heart failure: an update from the last years and a look at the near future.
1
—
—